Format

Send to

Choose Destination
J Surg Oncol. 2003 Dec;84(4):239-48.

Tumor markers and colorectal cancer: utility in management.

Author information

1
Price Institute of Surgical Research, Department of Surgery, University of Louisville, Kentucky 40292, USA.

Abstract

Colorectal cancer (CRC) is a leading cause of morbidity and mortality. Although genetic testing can screen for rare hereditary CRC syndromes, there is no ideal means of screening for sporadic forms of CRC. This review will focus on markers that are currently used in the management of sporadic CRC and their limitations, as well as possible future clinical applications.

PMID:
14756436
DOI:
10.1002/jso.10325
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center